Jacksonville, FL – Memorial Hospital of Jacksonville is now offering a breakthrough in obstructive sleep apnea (OSA) treatment called Inspire therapy which is FDA-approved, for those who are not able to use Continuous Positive Airway Pressure (CPAP) therapy.
OSA affects 22 million Americans. When left untreated, OSA can cause vehicle and workplace accidents, worsening mood and memory, stroke, heart attack, and even death. It occurs when the airway collapses during sleep and blocks the flow of oxygen to the brain. The brain senses a lack of oxygen and wakes the body up just long enough to take a breath, then falls back asleep. This cycle repeats throughout the night and causes poor, disruptive sleep.
Inspire works inside the body with a patient’s natural breathing process to treat sleep apnea. Mild stimulation opens the airway during sleep, allowing oxygen to flow naturally. The patient uses a small handheld remote to turn Inspire on before bed and off when they wake up.
“At Memorial Hospital we see many patients who have stopped using or are unable to tolerate CPAP,” said David Carlson, MD, otolaryngologist (ENT) at Memorial Hospital. “Inspire represents a significant advancement in treating sleep apnea and we are excited to have completed one of the first Inspire procedures for Jacksonville at Memorial. It is clinically proven to reduce sleep apnea events, has a high level of patient satisfaction and a high therapy adherence. We are excited to offer this promising therapy to sleep apnea patients who struggle with CPAP.”